No connection

Search Results

NOTV vs XWEL

NOTV
Inotiv, Inc.
BEARISH
Price
$0.24
Market Cap
$8.4M
Sector
Healthcare
AI Confidence
95%
XWEL
XWELL, Inc.
BEARISH
Price
$1.14
Market Cap
$9.0M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
NOTV
--
XWEL
--
Forward P/E
NOTV
-4.9
XWEL
-0.43
P/B Ratio
NOTV
0.08
XWEL
-1.04
P/S Ratio
NOTV
0.02
XWEL
0.31
EV/EBITDA
NOTV
26.68
XWEL
-3.37

Profitability

Gross Margin
NOTV
23.49%
XWEL
25.7%
Operating Margin
NOTV
-13.36%
XWEL
-45.07%
Profit Margin
NOTV
-13.5%
XWEL
-58.17%
ROE
NOTV
-49.76%
XWEL
--
ROA
NOTV
-3.14%
XWEL
-31.98%

Growth

Revenue Growth
NOTV
0.8%
XWEL
-4.2%
Earnings Growth
NOTV
--
XWEL
--

Financial Health

Debt/Equity
NOTV
4.37
XWEL
--
Current Ratio
NOTV
0.3
XWEL
0.46
Quick Ratio
NOTV
0.17
XWEL
0.33

Dividends

Dividend Yield
NOTV
--
XWEL
--
Payout Ratio
NOTV
0.0%
XWEL
0.0%

AI Verdict

NOTV BEARISH

NOTV exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is facing a liquidity crisis with a Current Ratio of 0.30 and a Quick Ratio of 0.17, suggesting it cannot meet its short-term obligations. High leverage (Debt/Equity of 4.37) combined with stagnant revenue growth (0.80%) and consistent earnings misses creates a high risk of insolvency. The catastrophic 5-year price decline of 98.8% and bearish insider activity further confirm a negative outlook.

Strengths
Positive Gross Margin (23.49%)
Extremely low Price-to-Sales ratio (0.02)
Extremely low Price-to-Book ratio (0.08)
Risks
Severe liquidity risk (Current Ratio 0.30)
Excessive leverage (Debt/Equity 4.37)
Consistent failure to meet earnings estimates (0/4 beats)
XWEL BEARISH

XWEL exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -1.04, indicating negative shareholder equity. The company is facing a liquidity crisis with a Current Ratio of 0.46 and a Quick Ratio of 0.33, suggesting it cannot meet its short-term obligations. While there has been a speculative 1-year price recovery and recent EPS 'beats,' these are relative to deeply negative expectations and do not offset the fundamental insolvency risks. The combination of declining revenue (-4.20% YoY) and negative margins makes the current valuation unsustainable.

Strengths
Low Price-to-Sales ratio (0.31) suggests the market has already priced in significant failure
Recent quarterly EPS surprises have been positive (beating negative estimates)
Short-term 1-year price performance shows speculative interest (+48%)
Risks
Extreme bankruptcy risk indicated by Piotroski F-Score of 1/9
Negative equity (P/B -1.04) indicates liabilities exceed assets
Severe liquidity shortage with a Current Ratio well below 1.0 (0.46)

Compare Another Pair

NOTV vs XWEL: Head-to-Head Comparison

This page compares Inotiv, Inc. (NOTV) and XWELL, Inc. (XWEL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile